These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37086950)

  • 1. Prognostic factors for significant 6-month recovery in dysthyroid optic neuropathy in a tertiary center: A series of 69 eyes in 38 patients.
    Vermot-Desroches V; Thia-Soui-Tchong K; Raymond P; Filip A; Orgiazzi J; Jouanneau E; Froment Tilikete C; Borson-Chazot F; Manet R; Abeillon Du Payrat J
    Ann Endocrinol (Paris); 2023 Aug; 84(4):430-439. PubMed ID: 37086950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sight-threatening Graves' orbitopathy: Twenty years' experience of a multidisciplinary thyroid-eye outpatient clinic.
    Tramunt B; Imbert P; Grunenwald S; Boutault F; Caron P
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):208-213. PubMed ID: 30339291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-center analysis of visual outcomes and associated factors after intravenous methylprednisolone treatment for dysthyroid optic neuropathy.
    Kemchoknatee P; Tangon D; Srisombut T
    BMC Ophthalmol; 2023 Jan; 23(1):32. PubMed ID: 36690985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete recovery of visual acuity as the main goal of treatment in patients with dysthyroid optic neuropathy.
    Miśkiewicz P; Rutkowska B; Jabłońska A; Krzeski A; Trautsolt-Jeziorska K; Kęcik D; Milczarek-Banach J; Pirko-Kotela K; Samsel A; Bednarczuk T
    Endokrynol Pol; 2016; 67(2):166-73. PubMed ID: 26884288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey.
    McKeag D; Lane C; Lazarus JH; Baldeschi L; Boboridis K; Dickinson AJ; Hullo AI; Kahaly G; Krassas G; Marcocci C; Marinò M; Mourits MP; Nardi M; Neoh C; Orgiazzi J; Perros P; Pinchera A; Pitz S; Prummel MF; Sartini MS; Wiersinga WM;
    Br J Ophthalmol; 2007 Apr; 91(4):455-8. PubMed ID: 17035276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The treatment effect of maximal orbital decompression surgery and intravenous glucocorticoids pulse therapy for dysthyroid optic neuropathy].
    Li TY; Wang Y
    Zhonghua Yan Ke Za Zhi; 2022 Sep; 58(9):669-675. PubMed ID: 36069086
    [No Abstract]   [Full Text] [Related]  

  • 7. Retinal nerve fiber layer thickness measured by optical coherence tomography predicts visual recovery after orbital decompression for dysthyroid optic neuropathy.
    Cheng S; Yu Y; You Y; Chen J; Pi X; Wang X; Jiang F
    Int Ophthalmol; 2021 Sep; 41(9):3121-3133. PubMed ID: 33945060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Visual Outcomes of Dysthyroid Optic Neuropathy After Surgical Orbital Decompression.
    Currò N; Guastella C; Pirola G; Calonghi B; Bottari de Castello A; Fazio MC; di Benedetto S; Minorini V; Daga M; Contarino A; Muller I; Arosio M; Viola F; Pignataro L; Salvi M
    Thyroid; 2023 Jun; 33(6):743-751. PubMed ID: 37140534
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic outcomes of high-dose intravenous steroids in the treatment of dysthyroid optic neuropathy.
    Currò N; Covelli D; Vannucchi G; Campi I; Pirola G; Simonetta S; Dazzi D; Guastella C; Pignataro L; Beck-Peccoz P; Ratiglia R; Salvi M
    Thyroid; 2014 May; 24(5):897-905. PubMed ID: 24417307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysthyroid optic neuropathy: atypical initial presentation and persistent visual loss.
    Mensah A; Vignal-Clermont C; Mehanna C; Morel X; Galatoire O; Jacomet PV; Morax S
    Orbit; 2009; 28(6):354-62. PubMed ID: 19929659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative clinical factors and visual outcomes following orbital decompression with dysthyroid optic neuropathy.
    Tagami M; Honda S; Azumi A
    BMC Ophthalmol; 2020 Jan; 20(1):30. PubMed ID: 31952487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into Current Management Strategies for Dysthyroid Optic Neuropathy: A Review.
    Tagami M; Honda S; Azumi A
    Clin Ophthalmol; 2022; 16():841-850. PubMed ID: 35330749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic outcomes and influence factors of maximal orbital decompression in the treatment of severe dysthyroid optic neuropathy].
    Wang Y; Li YY; Yang N; Ma R; Xiao LH
    Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):416-423. PubMed ID: 28606262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of medical and surgical decompression in patients with dysthyroid optic neuropathy.
    Garip Kuebler A; Wiecha C; Reznicek L; Klingenstein A; Halfter K; Priglinger S; Hintschich C
    Eye (Lond); 2020 Sep; 34(9):1702-1709. PubMed ID: 32366997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical characteristics of dysthyroid optic neuropathy].
    Elyashiv S; Skaat A; Ben Simon G; Huna-Baron R
    Harefuah; 2015 Feb; 154(2):98-102, 137. PubMed ID: 25856861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomography measurements in compressive optic neuropathy associated with dysthyroid orbitopathy.
    Park KA; Kim YD; In Woo K; Kee C; Han JC
    Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1617-1624. PubMed ID: 27169807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter study.
    Sears CM; Wang Y; Bailey LA; Turbin R; Subramanian PS; Douglas R; Cockerham K; Kossler AL
    Am J Ophthalmol Case Rep; 2021 Sep; 23():101111. PubMed ID: 34113737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Patients With Dysthyroid Optic Neuropathy Treated With Intravenous Corticosteroids and/or Orbital Decompression Surgery: A Systematic Review and Meta-analysis.
    Wang M; Jiang X; Geng J; Hui S; Li D
    J Clin Endocrinol Metab; 2023 Sep; 108(10):2717-2727. PubMed ID: 37066814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Ability of Barrett's Index and Presence of Intracranial Fat Prolapse in Dysthyroid Optic Neuropathy.
    Kemchoknatee P; Chenkhumwongse A; Dheeradilok T; Srisombut T
    Clin Ophthalmol; 2022; 16():2569-2578. PubMed ID: 35983164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysthyroid Optic Neuropathy: Treatment with Additional Intravenous Methylprednisolone Pulses after the Basic Schedule Is Associated with Stabilization or Further Improvement of Clinical Outcome.
    Pelewicz M; Rymuza J; Pelewicz K; Miśkiewicz P
    J Clin Med; 2022 Apr; 11(8):. PubMed ID: 35456161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.